 |
|
Natural History and Prognostic Factors of Primary Hepatocellular Carcinoma: Study of 70 Untreated Patients
Ung Bong Kim, Chang Jun Doo, Seung Hoon Baek, Joo Hyoung Kim, Hong Bock Lee, Sung Ki Park, Jong Hoon Byun
Korean J Intern Med. 1989;4(2):136-142. Published online 1989 Jul 1 DOI: https://doi.org/10.3904/kjim.1989.4.2.136
|
|
Citations to this article as recorded by
 Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses
Chai Hong Rim, Sunmin Park, Won Sup Yoon, In-Soo Shin, Hee Chul Park
International Journal of Radiation Biology.2023; 99(3): 419. CrossRef Hepatocellular Carcinoma (HCC) in North-Western India: A Retrospective Study Focusing on Epidemiology, Risk Factors, and Survival
Sweta Soni, Puneet Pareek, Satya narayan, Amrita Rakesh, Abhilasha Abhilasha
Journal of Gastrointestinal Cancer.2022; 53(4): 921. CrossRef Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients
Leung Li, Stephen L. Chan, Frankie Mo, Edwin P. Hui, Jane Koh, Allen KC Chan, Nelson LS Tang, Cheuk M. Chu, Joyce Hui, Kit F. Lee, Simon Yu, Winnie Yeo
Quality of Life Research.2019; 28(9): 2597. CrossRef A simple prognostic scoring system for patients with unresectable hepatocellular carcinoma treated by chemo-embolization
Igor Dvorchik, Brian I. Carr
Cancer Detection and Prevention.2007; 31(2): 154. CrossRef Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin
Robert G. Gish, Camillo Porta, Lucian Lazar, Paul Ruff, Ronald Feld, Adina Croitoru, Lynn Feun, Krzysztof Jeziorski, John Leighton, Jennifer Knox, José Gallo, Gerard T. Kennealey
Journal of Clinical Oncology.2007; 25(21): 3069. CrossRef Simple Clinical Prognostic Model for Hepatocellular Carcinoma in Developing Countries and Its Validation
Chee Kiat Tan, Ngai Moh Law, Han Seong Ng, David Machin
Journal of Clinical Oncology.2003; 21(12): 2294. CrossRef Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5‐fluorouracil, epirubicin and mitomycin C
Hiroshi Seno, Kazuki Ito, Koichi Kojima, Nobuaki Nakajima, Tsutomu Chiba
Journal of Gastroenterology and Hepatology.1999; 14(8): 811. CrossRef
|